Does CENEGERMIN-BKBJ Cause Therapy interrupted? 488 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 488 reports of Therapy interrupted have been filed in association with CENEGERMIN-BKBJ. This represents 4.1% of all adverse event reports for CENEGERMIN-BKBJ.
488
Reports of Therapy interrupted with CENEGERMIN-BKBJ
4.1%
of all CENEGERMIN-BKBJ reports
3
Deaths
48
Hospitalizations
How Dangerous Is Therapy interrupted From CENEGERMIN-BKBJ?
Of the 488 reports, 3 (0.6%) resulted in death, 48 (9.8%) required hospitalization.
Is Therapy interrupted Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CENEGERMIN-BKBJ. However, 488 reports have been filed with the FAERS database.
What Other Side Effects Does CENEGERMIN-BKBJ Cause?
Eye pain (5,847)
Eye irritation (1,871)
Product dose omission issue (1,335)
Ocular hyperaemia (1,226)
Photophobia (1,065)
Vision blurred (944)
Wrong technique in product usage process (899)
Eye swelling (847)
Ocular discomfort (797)
Lacrimation increased (737)
What Other Drugs Cause Therapy interrupted?
ADALIMUMAB (5,755)
ETANERCEPT (3,397)
RELUGOLIX (3,251)
CERTOLIZUMAB PEGOL (3,209)
LENALIDOMIDE (2,724)
UPADACITINIB (1,741)
ABATACEPT (1,726)
CLOZAPINE (1,722)
AMIKACIN (1,283)
TOFACITINIB (1,182)
Which CENEGERMIN-BKBJ Alternatives Have Lower Therapy interrupted Risk?
CENEGERMIN-BKBJ vs CENOBAMATE
CENEGERMIN-BKBJ vs CEPHALEXIN
CENEGERMIN-BKBJ vs CERITINIB
CENEGERMIN-BKBJ vs CERLIPONASE ALFA
CENEGERMIN-BKBJ vs CERTICAN